Kingston Cardiology Associates

Kingston Cardiology Associates is a biotechnology and healthcare startup founded in 2020. The company's slogan, "Empowering patients with a comprehensive suite of noninvasive cardiovascular diagnostics and unparalleled professional care in a welcoming environment," encapsulates its mission to provide patients with access to various noninvasive diagnostic technologies. These technologies include exercise stress testing, ordinary exercise, nuclear or stress echocardiography, an electrocardiogram, and an echocardiogram, including a transesophageal echocardiogram. This comprehensive suite allows for thorough monitoring of the cardiovascular system. Kingston Cardiology Associates is committed to offering professional service in a welcoming environment. As of now, there is no specific information available regarding the company's headquarters, last investment, or the investors involved. This innovative approach to cardiovascular diagnostics and care positions Kingston Cardiology Associates as a promising player in the field of noninvasive cardiovascular health monitoring and care.